• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咔唑衍生物作为PPARα/γ双重激动剂和抗氧化剂的设计、合成与评价

Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.

作者信息

Kumar Rakesh, Ramachandran Uma, Srinivasan Krishnamoorthy, Ramarao Poduri, Raichur Suryaprakash, Chakrabarti Ranjan

机构信息

Department of Pharmaceutical Technology, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar 160 062, India.

出版信息

Bioorg Med Chem. 2005 Jul 1;13(13):4279-90. doi: 10.1016/j.bmc.2005.04.018.

DOI:10.1016/j.bmc.2005.04.018
PMID:15869880
Abstract

A series of hydroxycarbazole derivatives were synthesized and evaluated for PPAR alpha/gamma dual agonist as well as antioxidant activities. While most compounds showed good antioxidant activity, some compounds were identified as potential PPAR alpha/gamma dual agonists as well. Compounds 10a and 16 were found to be active in animal studies.

摘要

合成了一系列羟基咔唑衍生物,并对其作为过氧化物酶体增殖物激活受体α/γ双重激动剂的活性以及抗氧化活性进行了评估。虽然大多数化合物表现出良好的抗氧化活性,但也有一些化合物被鉴定为潜在的过氧化物酶体增殖物激活受体α/γ双重激动剂。化合物10a和16在动物研究中被发现具有活性。

相似文献

1
Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.咔唑衍生物作为PPARα/γ双重激动剂和抗氧化剂的设计、合成与评价
Bioorg Med Chem. 2005 Jul 1;13(13):4279-90. doi: 10.1016/j.bmc.2005.04.018.
2
PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.PAR-5359是一种平衡良好的PPARα/γ双重激动剂,在体外和体内均表现出同等的抗糖尿病和降血脂活性。
Eur J Pharmacol. 2008 Oct 24;595(1-3):119-25. doi: 10.1016/j.ejphar.2008.07.066. Epub 2008 Aug 12.
3
Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia.发现用于治疗2型糖尿病和血脂异常的新型过氧化物酶体增殖物激活受体α/γ双重激动剂系列。
J Med Chem. 2005 Apr 7;48(7):2262-5. doi: 10.1021/jm048993p.
4
Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.带有4-噻唑基-苯氧基尾基的茚满乙酸衍生物,一类新型强效PPARα/γ/δ泛激动剂:合成、构效关系及体内疗效
J Med Chem. 2007 Mar 8;50(5):984-1000. doi: 10.1021/jm061299k. Epub 2007 Feb 3.
5
Design, synthesis, and evaluation of novel aryl-tetrahydropyridine PPARalpha/gamma dual agonists.新型芳基四氢吡啶PPARα/γ双重激动剂的设计、合成与评价
Bioorg Med Chem Lett. 2008 Sep 15;18(18):4993-6. doi: 10.1016/j.bmcl.2008.08.020. Epub 2008 Aug 12.
6
Synthesis and evaluation of a series of benzopyran derivatives as PPAR alpha/gamma agonists.一系列苯并吡喃衍生物作为过氧化物酶体增殖物激活受体α/γ激动剂的合成与评价
Eur J Med Chem. 2008 Nov;43(11):2428-35. doi: 10.1016/j.ejmech.2008.01.029. Epub 2008 Feb 2.
7
Design and biological evaluation of novel, balanced dual PPARalpha/gamma agonists.新型平衡型双PPARα/γ激动剂的设计与生物学评价
ChemMedChem. 2009 Jun;4(6):951-6. doi: 10.1002/cmdc.200800425.
8
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.新型过氧化物酶体增殖物激活受体α/γ双重激动剂N-[(4-甲氧基苯氧基)羰基]-N-[[4-[2-(5-甲基-2-苯基-4-恶唑基)乙氧基]苯基]甲基]甘氨酸[muraglitazar/BMS-298585]的设计与合成,该化合物具有有效的降血糖和降血脂活性。
J Med Chem. 2005 Mar 24;48(6):2248-50. doi: 10.1021/jm0496436.
9
Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.新型受限间位取代苯基丙酸作为过氧化物酶体增殖物激活受体α和γ双重激动剂的设计、合成及生物学评价
J Med Chem. 2008 Oct 23;51(20):6318-33. doi: 10.1021/jm8003416. Epub 2008 Oct 1.
10
Substituted indanylacetic acids as PPAR-alpha-gamma activators.
Bioorg Med Chem Lett. 2006 Jan 15;16(2):297-301. doi: 10.1016/j.bmcl.2005.10.008. Epub 2005 Nov 3.

引用本文的文献

1
Investigations on Binding Pattern of Kinase Inhibitors with PPAR: Molecular Docking, Molecular Dynamic Simulations, and Free Energy Calculation Studies.激酶抑制剂与过氧化物酶体增殖物激活受体(PPAR)结合模式的研究:分子对接、分子动力学模拟及自由能计算研究
PPAR Res. 2017;2017:6397836. doi: 10.1155/2017/6397836. Epub 2017 Feb 22.
2
DESIGN, SYNTHESIS, AND EVALUATION OF CARBAZOLE ANALOGS AS POTENTIAL CYTOCHROME P450 INHIBITORS.咔唑类似物作为潜在细胞色素P450抑制剂的设计、合成及评估
J Undergrad Chem Res. 2013 Sep;12(4):92-95.
3
Palladium-catalyzed method for the synthesis of carbazoles via tandem C-H functionalization and C-N bond formation.
通过串联C-H官能化和C-N键形成合成咔唑的钯催化方法。
J Org Chem. 2008 Oct 3;73(19):7603-10. doi: 10.1021/jo801273q. Epub 2008 Aug 29.
4
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity.将快速MTT甲臜胞吐测定法与MC65保护测定法相结合,发现咔唑类似物可作为β-淀粉样蛋白寡聚体诱导细胞毒性的小分子抑制剂。
Brain Res. 2007 Jan 26;1130(1):223-34. doi: 10.1016/j.brainres.2006.10.093. Epub 2006 Dec 8.